A nationwide study of 331 rare diseases among 58 million individuals: prevalence, demographics, and COVID-19 outcomes (2023)

First Author: Thygesen J

Attributed to: Phase 1 COVID-19 Data and Connectivity – National Core Study (Phase 1 D&C-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.10.12.23296948

Publication URI: http://dx.doi.org/10.1101/2023.10.12.23296948

Type: Preprint